Skip to content
In English |
En español
Search
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-10 of 10 for your search:
Cancer Type/Condition:
Retinoblastoma
Country:
U.S.A.
Trial Type:
Treatment
Trial Status:
Active
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Phase III Study of Systemic Chemotherapy Comprising Vincristine, Carboplatin, and Etoposide, Subtenon Carboplatin, and Local Ophthalmic Therapy in Pediatric Patients With Group C or D Intraocular Retinoblastoma
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
Under 18
Sponsor:
NCI
Protocol IDs:
COG-ARET0231
, ARET0231, NCT00072384
2.
Study of Treatment for Patients With Cancer of the Eye -Retinoblastoma
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
18 and under
Sponsor:
Other
Protocol IDs:
RET5
, NCT00186888
3.
Phase III Study of Adjuvant Vincristine, Carboplatin, and Etoposide or Observation Only in Patients With Newly Diagnosed Unilateral Retinoblastoma With or Without Histopathologic High-Risk Features After Enucleation
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
6 and under
Sponsor:
NCI
Protocol IDs:
COG-ARET0332
, ARET0332, NCT00335738
4.
Phase III Study of Multimodality Therapy Comprising Induction Chemotherapy, High-Dose Consolidation Chemotherapy, Autologous Stem Cell Transplantation, and/or Radiotherapy in Children With Extraocular Retinoblastoma
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
10 and under
Sponsor:
NCI
Protocol IDs:
COG-ARET0321
, ARET0321, NCT00554788
5.
Phase II Study of Intrathecal Iodine I 131 Monoclonal Antibody 3F8 in Patients With GD2-Expressing Central Nervous System or Leptomeningeal Neoplasms
Phase:
Phase II
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
Any age
Sponsor:
Other
Protocol IDs:
MSKCC-05122
, NCT00445965
6.
Proton Beam Radiation Therapy for Intraocular and Periocular Retinoblastoma
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
Not specified
Sponsor:
Other
Protocol IDs:
2005-0883
, NCT00432445
7.
Phase II Study of Cixutumumab in Patients With Relapsed or Refractory Solid Tumors
Phase:
Phase II
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
6 months to 30 years
Sponsor:
NCI
Protocol IDs:
COG-ADVL0821
, ADVL0821, NCT00831844
8.
Valproate and Etoposide for Patients With Neuronal Tumors and Brain Metastases
Phase:
Phase I
Type:
Treatment
Status:
Active
Age:
Any age
Sponsor:
Other
Protocol IDs:
2007-0370
, NCT00513162
9.
Phase I Study of Total Marrow Irradiation With Helical Tomotherapy Image-Guided Intensity-Modulated Radiotherapy Followed by Alkylator-Intense Conditioning Comprising Busulfan, Melphalan, and Thiotepa and Autologous CD34+ Hematopoietic Progenitor Cell Transplantation in Patients With High-Risk or Relapsed Solid Tumors
Phase:
Phase I
Type:
Biomarker/Laboratory analysis, Diagnostic, Treatment
Status:
Active
Age:
70 and under
Sponsor:
NCI
Protocol IDs:
UMN-2005LS023
, UMN-2005LS023, UMN-MT2004-30, NCT00623077
10.
A Study of the Effectiveness of a Local Injection of Chemotherapy for Retinoblastoma
Phase:
No phase specified
Type:
Treatment
Status:
Active
Age:
Not specified
Sponsor:
Other
Protocol IDs:
08-885
, no grant, NCT00857519
Select All on Page
Help with Results
